StocksFundsScreenerSectorsWatchlists

Latest Sarissa Capital Management LP Stock Portfolio

$648Million

Equity Portfolio Value
Last Reported on: 14 Feb, 2024

About Sarissa Capital Management LP and it’s 13F Hedge Fund Stock Holdings

In it's latest 13F Holdings report, Sarissa Capital Management LP reported an equity portfolio of $742.4 Millions as of 30 Sep, 2023.

The top stock holdings of Sarissa Capital Management LP are ALKS, BIIB, IRWD. The fund has invested 26.6% of it's portfolio in ALKERMES PLC and 22.3% of portfolio in BIOGEN INC.

They significantly reduced their stock positions in MERSANA THERAPEUTICS INC (MRSN) and ALKERMES PLC (ALKS). The fund showed a lot of confidence in some stocks as they added substantially to AMARIN CORP PLC (AMRN) and NEUROCRINE BIOSCIENCES INC (NBIX).

New Buys

No new stocks were added by Sarissa Capital Management LP

Additions

Ticker% Inc.
AMARIN CORP PLC137
BIOCRYST PHARMACEUTICALS INC29.03
NEUROCRINE BIOSCIENCES INC28.42
GILEAD SCIENCES INC16.84

Additions to existing portfolio by Sarissa Capital Management LP

Reductions

None of the existing positions were reduced by Sarissa Capital Management LP

Sold off

Ticker$ Sold
ALKERMES PLC-197,252,000
MERSANA THERAPEUTICS INC-698,500

Sarissa Capital Management LP got rid off the above stocks

Current Stock Holdings of Sarissa Capital Management LP

Last Reported on: 14 Feb, 2024
TickerNamesorted ascending% PortfolioShares Held$ ValueType% ChangeOptions
ALKSALKERMES PLC0.000.000.00SOLD OFF-100
AMRNAMARIN CORP PLC3.3324,850,60021,620,000ADDED137
BCRXBIOCRYST PHARMACEUTICALS INC0.921,000,0005,990,000ADDED29.03
BIIBBIOGEN INC25.64643,000166,389,000UNCHANGED0.00
GILDGILEAD SCIENCES INC13.431,075,40087,118,200ADDED16.84
INVAINNOVIVA INC17.997,277,000116,723,000UNCHANGED0.00
IRWDIRONWOOD PHARMACEUTICALS INC28.9016,390,000187,502,000UNCHANGED0.00
MRSNMERSANA THERAPEUTICS INC0.000.000.00SOLD OFF-100
NBIXNEUROCRINE BIOSCIENCES INC9.54470,00061,927,200ADDED28.42
RGLSREGULUS THERAPEUTICS INC0.04185,183237,034UNCHANGED0.00
VORVOR BIOPHARMA INC0.21618,0001,390,500UNCHANGED0.00